Post-concussion syndrome is a complex disorder in which various symptoms — such as headaches and dizziness — last for weeks and sometimes months after the injury that caused the concussion.
The symptoms of this disease are includes Headaches, Dizziness, Fatigue, Irritability, Anxiety, Insomnia, Loss of concentration and memory, Noise and light sensitivity, vertigo,memory problems,trouble concentrating,sleeping problems,insomnia,restlessness, irritability,apathy,depression,anxiety,personality changes.
There is no specific treatment for post-concussion syndrome. Instead, your doctor will treat the individual symptoms you're experiencing. The types of symptoms and their frequency are unique to each person.Examples include: Amitriptyline. This medication has been widely used for post-traumatic injuries, as well as for symptoms commonly associated with post-concussion syndrome, such as irritability, dizziness and depression. Amitriptyline may be combined with propranolol (Inderal, Innopran XL) to treat migraine-type headaches. Topiramate. Commonly used to treat migraines, topiramate (Qudexy XR, Topamax, Trokendi XR) may be effective in reducing headaches after head injury. Common side effects of topiramate include weight loss and cognitive problems. Gabapentin. Gabapentin (Gralise, Neurontin) is frequently used to treat a variety of types of pain and may be helpful in treating post-traumatic headaches. A common side effect of gabapentin is drowsiness.
recorded signs and symptoms, history of previous diseases, medications, and lifestyle factors and measured serum protein S-100B on admission in a series of 172 consecutive MHI patients admitted into the emergency room of a general hospital. A modified Rivermead Post-Concussion Symptoms Questionnaire was used to identify the patients with and without PCSs 1 month after the injury. We identified 37 patients with MHI who developed PCSs (22%). Odds ratios (OR) and 95% confidence intervals (CI) after adjustment for possible confounding variables were calculated by logistic regression. Independent early risk factors for PCSs in the MHI patients were skull fracture (OR 8.0, 95% CI 2.6-24.6), serum protein S-100B >/= 0.50 microg/l (OR 5.5, 95% CI 1.6-18.6), dizziness (OR 3.1, 95% CI 1.2-8.0), and headache (OR 2.6, 95% CI 1.0-6.5). Serum protein S-100B proved to be a specific, but not sensitive predictor of PCSs